Following Sandra Day O'Connor's announcement of her dementia, and possibly Alzheimer's, diagnosis, Dr. Todd Golde explains a dementia diagnosis, current treatments and his hope for the future.
Melissa Armstrong, M.D., an assistant professor of neurology, partnered with the Lewy Body Dementia Association to survey the families of patients who had dementia with Lewy bodies.
In a recent editorial in JAMA Neurology, a group of neurologists at at The Fixel Center for Neurological Diseases at UF Health discuss medication trends for Parkinson's disease dementia.
In The Conversation, Dr. Melissa Armstrong explains LBD, how it's diagnosed and current avenues for researching the disease.
A mouse-model study led by Drs. Paramita Chakrabarty and Todd Golde describes how their team bioengineered a naturally occurring protein to enable it to bind to amyloid beta protein in the brain.
Bill Gates recently invested in a venture fund to improve diagnostic testing for Alzheimer's. Steven DeKosky, M.D., discusses the importance of an early diagnosis for patients and researchers.
Glenn Smith, Ph.D., ABPP-cn, chair of the department of clinical and health psychology, recently commented on the state of Alzheimer's disease research in a Citrus County Chronicle feature story.
Newly renovated high-tech labs supporting cognitive aging and human MRI-based research are now up and running at the MBI.
UF researchers received a $572,000 grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to conduct a first of its kind study on the effects of bariatric (weight–loss) surgery on brain function, thinking, and memory.